Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vyvgart
Pharma
Argenx isn't sweating over Vyvgart competitors: exec
Despite some recent competition from UCB, argenx is confident that it’s “just at the beginning of the growth curve” for Vyvgart in myasthenia gravis.
Fraiser Kansteiner
May 9, 2024 4:56pm
Argenx gears up to launch Vyvgart in next potential indication
Apr 16, 2024 2:24pm
Argenx starts unbranded push ahead of hoped-for label expansion
Feb 29, 2024 12:54pm
Argenx reports another swing and miss for Vyvgart Hytrulo
Dec 20, 2023 11:16am
Argenx's Vyvgart comes up short of placebo in ITP trial
Nov 28, 2023 11:20am
Subcutaneous Vyvgart helps Argenx treat a 'broader population'
Nov 1, 2023 9:35am